Literature DB >> 21271014

[New paradigms and challenges in cervical cancer prevention and control in Latin America].

Maribel Almonte1, Raúl Murillo, Gloria Inés Sánchez, José Jerónimo, Jorge Salmerón, Catterina Ferreccio, Eduardo Lazcano-Ponce, Rolando Herrero.   

Abstract

Cervical cancer continues to be a significant health problem in Latin America. The use of conventional cytology to detect precancerous cervical lesions has had almost no major impact on reducing cervical cancer incidence and mortality rates, which are still high in the region. The availability of new screening tools to detect precancerous lesions provide great opportunities for cervical cancer prevention in the region, as do highly efficacious HPV vaccines able to prevent nearly all lesions associated with HPV-16 and -18 when applied before viral exposure. This paper summarizes the scientific evidence and regional experiences related to: i) the use of HPV testing and visual inspection after the application of acetic acid (VIA) in primary screening and ii) the implementation of adolescent HPV vaccination programs. Finally, we outline a number of recommendations for different resource settings. The feasibility of implementing successful and sustainable national cervical cancer prevention programs in Latin American countries in the region will depend on health priorities and the availability of infrastructure and health personnel--as determined by rigorous local situational analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21271014     DOI: 10.1590/s0036-36342010000600010

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  19 in total

1.  Bolivian health providers' attitudes toward alternative technologies for cervical cancer prevention: a focus on visual inspection with acetic acid and cryotherapy.

Authors:  Analía Romina Stormo; Victor Conde Altamirano; Macarena Pérez-Castells; David Espey; Haydee Padilla; Karen Panameño; Milton Soria; Carlos Santos; Mona Saraiya; Silvana Luciani
Journal:  J Womens Health (Larchmt)       Date:  2012-07-20       Impact factor: 2.681

2.  Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.

Authors:  Monserrat Balanda; Andrea Quiero; Nicolás Vergara; Gloria Espinoza; Héctor San Martín; Giovanna Rojas; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

3.  Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.

Authors:  Ana Cecilia Rodríguez; Carlos Ávila; Rolando Herrero; Allan Hildesheim; Mark E Sherman; Robert D Burk; Jorge Morales; Mario Alfaro; Diego Guillén; María Ethel Trejos; Rosa María Vargas; Guillermo Torres; Mark Schiffman
Journal:  Int J Cancer       Date:  2017-02-07       Impact factor: 7.396

Review 4.  HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Authors:  F Xavier Bosch; Claudia Robles; Mireia Díaz; Marc Arbyn; Iacopo Baussano; Christine Clavel; Guglielmo Ronco; Joakim Dillner; Matti Lehtinen; Karl-Ulrich Petry; Mario Poljak; Susanne K Kjaer; Chris J L M Meijer; Suzanne M Garland; Jorge Salmerón; Xavier Castellsagué; Laia Bruni; Silvia de Sanjosé; Jack Cuzick
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

5.  Cervical and female breast cancers in the Americas: current situation and opportunities for action.

Authors:  Silvana Luciani; Anna Cabanes; Elisa Prieto-Lara; Vilma Gawryszewski
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

Review 6.  Epidemiology of cervical cancer in Colombia.

Authors:  Nubia Muñoz; Luis Eduardo Bravo
Journal:  Colomb Med (Cali)       Date:  2012-12-30

7.  Current cervical cancer screening knowledge, awareness, and practices among U.S. affiliated pacific island providers: opportunities and challenges.

Authors:  Julie S Townsend; Analía Romina Stormo; Katherine B Roland; Lee Buenconsejo-Lum; Susan White; Mona Saraiya
Journal:  Oncologist       Date:  2014-03-25

8.  HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico.

Authors:  Yvonne N Flores; David M Bishai; Attila Lorincz; Keerti V Shah; Eduardo Lazcano-Ponce; Mauricio Hernández; Víctor Granados-García; Ruth Pérez; Jorge Salmerón
Journal:  Cancer Causes Control       Date:  2010-12-18       Impact factor: 2.506

9.  High-risk HPV infection after five years in a population-based cohort of Chilean women.

Authors:  Catterina Ferreccio; Vanessa Van De Wyngard; Fabiola Olcay; M Angélica Domínguez; Klaus Puschel; Alejandro H Corvalán; Silvia Franceschi; Peter Jf Snijders
Journal:  Infect Agent Cancer       Date:  2011-11-16       Impact factor: 2.965

Review 10.  Cancer in indigenous people in Latin America and the Caribbean: a review.

Authors:  Suzanne P Moore; David Forman; Marion Piñeros; Sdenka M Fernández; Marceli de Oliveira Santos; Freddie Bray
Journal:  Cancer Med       Date:  2013-12-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.